文献速递膀胱癌与上尿路尿路上皮癌前列腺癌

前列腺癌放疗后膀胱癌患者行根治性膀胱切除术的死亡率

Mortality rates in radical cystectomy patients with bladder cancer after radiation therapy for prostate cancer.
PubMed 文献 · BJU Int · 2024-10-27

基于监测、流行病学和最终结果数据库(2004-2020)的人群研究,比较放疗后继发性膀胱癌(RT-BCa)与原发性膀胱癌(pBCa)患者行根治性膀胱切除术(RC)后的肿瘤特异性死亡率(CSM)和其他原因死亡率(OCM)。结果显示两组CSM无差异,但RT-BCa整体及非器官局限(NOC)亚组的OCM更高,其中既往接受外照射放疗(EBRT)者OCM升高。

要点

  • RT-BCa与pBCa行RC后肿瘤特异性死亡率无显著差异。
  • RT-BCa整体其他原因死亡率约为pBCa的1.3倍。
  • NOC亚组中RT-BCa其他原因死亡率约为pBCa的1.5倍。

核心结论

  • RT-BCa行RC的肿瘤特异性死亡率与pBCa行RC相似,与疾病分期无关。
  • 既往接受EBRT者在NOC亚组其他原因死亡率显著更高。

研究设计与样本

  • 基于监测、流行病学和最终结果数据库(2004-2020)的人群研究。
  • 纳入T2-4N0-3M0膀胱癌行RC的患者,包括既往因前列腺癌接受外照射放疗(EBRT)或近距离放疗者及pBCa患者。
  • 共9957例RC患者,其中RT-BCa 347例(3%),pBCa 9610例(97%)。
  • 采用累积发病率图和多变量竞争风险回归(CRR)模型评估CSM,并额外调整OCM。
  • 按器官局限(OC:T2N0M0)和非器官局限(NOC:T3-4和/或N1-3)疾病重复分析。

主要发现

  • 多变量CRR模型显示,整体比较中CSM无差异(P=0.8)。
  • OC和NOC亚组中CSM亦无差异(P=0.8和0.7)。
  • RT-BCa为整体队列OCM独立预测因素,升高1.3倍。
  • RT-BCa为NOC疾病OCM独立预测因素,升高1.5倍。
  • NOC疾病敏感性分析中,EBRT与更高的OCM率相关(风险比1.5)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To conduct a population-based study examining cancer-specific mortality (CSM) and other-cause mortality (OCM) differences in patients with radiation-induced secondary bladder cancer (RT-BCa) vs those with primary bladder cancer (pBCa) undergoing radical cystectomy (RC). METHODS: Within the Surveillance, Epidemiology, and End Results database (2004-2020), we identified patients with T2-4N0-3M0 bladder cancer treated with RC, who had previously been treated with external beam radiation therapy (EBRT) or brachytherapy for prostate cancer, as well as patients with T2-4N0-3M0 pBCa treated with RC. Cumulative incidence plots and multivariable competing risks regression (CRR) models were used to assess CSM after additional adjustment for OCM. The same methodology was then repeated based on organ-confined (OC: T2N0M0) and non-organ-confined (NOC: T3-4 and/or N1-3) disease. RESULTS: Of 9957 RC patients, RT-BCa was identified in 347 (3%) compared with 9610 (97%) who had pBCa. In multivariable CRR models, no CSM differences were recorded in the overall comparison (P = 0.8), nor in sub-groups based on OC and NOC disease (P = 0.8 and 0.7, respectively). Conversely, multivariable CRR models identified RT-BCa as an independent predictor of 1.3-fold higher OCM in the overall cohort and of 1.5-fold higher OCM in those with NOC disease. In a sensitivity analysis of patients with NOC disease, EBRT was associated with higher OCM rates (hazard ratio 1.5). By contrast, OCM rates were not different in those with OC disease (P = 0.8). CONCLUSION: Our study showed that RC for RT-BCa was associated with similar CSM rates as RC for pBCa, regardless of disease stage. However, patients who had undergone EBRT exhibited significantly higher OCM in the NOC sub-group.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. de Angelis M, Siech C, Di Bello F, et al. Mortality rates in radical cystectomy patients with bladder cancer after radiation therapy for prostate cancer. BJU Int. 2024. PMID: 39462874. doi:10.1111/bju.16571

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。